|
|
Volumn 84, Issue 4, 1999, Pages 454-458
|
|
Future cardiovascular end point studies: Where will the research take us?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CHOLESTEROL;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
HYPOCHOLESTEROLEMIC AGENT;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
SIMVASTATIN;
CARDIOVASCULAR DISEASE;
CLINICAL RESEARCH;
CLINICAL TRIAL;
CORONARY ARTERY ATHEROSCLEROSIS;
CORONARY ARTERY BYPASS SURGERY;
CORONARY ARTERY DILATATION;
DIET;
HUMAN;
HYPERCHOLESTEROLEMIA;
LIFESTYLE;
PATIENT COMPLIANCE;
PRIMARY PREVENTION;
PRIORITY JOURNAL;
PUBLIC HEALTH;
REVIEW;
RISK FACTOR;
|
|
EID: 0033566857
PISSN: 00029149
EISSN: None
Source Type: Journal
DOI: 10.1016/S0002-9149(99)00332-X Document Type: Note |
|
Times cited : (11)
|
|
References (42)
|
